Literature DB >> 20563467

Surgical biatrial ablation of atrial fibrillation: initial results.

João Roberto Breda1, Ricardo Gitti Ragognette, Ana Silvia Castaldi Ragognetti Breda, Danilo Bortolloto Gurian, Louise Horiuti, Leandro Neves Machado, Andréa Cristina de Oliveira Freitas, Adilson Casemiro Pires.   

Abstract

OBJECTIVE: To evaluate the results of intraoperative radiofrequency ablation with biatrial procedure in the treatment of chronic atrial fibrillation in patients with associated cardiac disease.
METHODS: Between February 2008 and May 2009, 15 consecutive patients were underwent mitral valve procedure plus modified radiofrequency biatrial ablation of chronic atrial fibrillation. The mean age was 47.73 +/- 9.85 years and 60% were male. The mean left atrial diameter was 55.06 +/- 7.56 mm.
RESULTS: There were no hospital mortality or complications related to radiofrequency ablation. The mean follow-up period was 7 +/- 4 months. At the time of hospital discharge nine (60%) patients were in sinus rhythm. After a mean follow-up period 11 (73.3%) were in sinus rhythm.
CONCLUSION: Intraoperative biatrial radiofrequency ablation is a safe and effective technique for the treatment of chronic atrial fibrillation, with satisfactory midterms outcomes in terms of conversion to sinus rhythm.

Entities:  

Mesh:

Year:  2010        PMID: 20563467     DOI: 10.1590/s0102-76382010000100012

Source DB:  PubMed          Journal:  Rev Bras Cir Cardiovasc


  2 in total

Review 1.  Surgical Ablation of Atrial Fibrillation Using Energy Sources.

Authors:  Alexandre Visconti Brick; Domingo Marcolino Braile
Journal:  Braz J Cardiovasc Surg       Date:  2015 Nov-Dec

2.  Surgical Treatment of Atrial Fibrillation in Patients with Rheumatic Valve Disease.

Authors:  Ernesto Koehler Chavez; Alexandre Siciliano Colafranceschi; Andrey José de Oliveira Monteiro; Leonardo Secchin Canale; Evandro Tinoco Mesquita; Clara Weksler; Odilon Nogueira Barbosa; Anderson Oliveira
Journal:  Braz J Cardiovasc Surg       Date:  2017 May-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.